News & Events

ATP's four portfolio companies have delivered exceptional results in 2009 and following are some recent highlights:

	Celgene to Acquire Gloucester Pharmaceuticals December 7 2009 "Celgene Corporation (NASDAQ:CELG) and Gloucester Pharmaceuticals Inc., a privately held pharmaceutical company, announced a definitive merger agreement under which Celgene Corporation will acquire Gloucester Pharmaceuticals...."

	Tokai eyes novel weapon to battle prostate cancer November 27 2009 "Tokai Pharmaceuticals has begun a clinical trial for a new prostate cancer drug candidate after quietly raising cash over the...."

	Aileron Therapeutics Collaborators Publish In Vivo Research in Nature Showing Stapled Peptides Achieve the First Direct Inhibition of the Notch1 Transcription Factor Oncogene November 11 2009 "Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides...." Link to Abstract

	Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer November 10 2009 "Tokai Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the...."

	FDA Approves Gloucester Pharmaceuticals' ISTODAX® for Patients with Cutaneous T-cell Lymphoma November 5 2009 "Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin)...."

	FDA Advisory Committee Recommends Gloucester Pharmaceuticals’ Romidepsin for Approval for Cutaneous T-cell Lymphoma September 2 2009 "Gloucester Pharmaceuticals announced today that the Oncologic Drug Advisory Committee (ODAC) appointed by the...."

	Gloucester raises $29 million August 25 2009 "Gloucester Pharmaceuticals Inc. (Cambridge, Mass.) raised $29 million in a series D round led by new investor Novo A/S. ...."

	HeartWare International Surpasses 50 Implants In The US August 21 2009 "HeartWare International, Inc. (NASDAQ: HTWR) (ASX: HIN) today announced that HeartWare has surpassed 50 implants in the...."

	HeartWare International, Inc. Closes US$60 Million Financing August 17 2009 "HeartWare International, Inc. (NASDAQ: HTWR) (ASX: HIN) announced today the completion of its offering of approximately...."

	Drug giants pump $40m into Aileron June 9 2009 "Four global pharmaceutical companies have joined in a consortium to provide $40 million in financing to Aileron Therapeutics...."

	Aileron Therapeutics Closes $40M Financing To Advance Stapled Peptide Platform June 8 2009 "Company Developing Novel Class of Stapled Peptide Drugs as Technology Platform for Historically Undruggable Targets...."

	"Emerging Drug Developer" Tokai Pharmaceuticals June 1 2009 "Seth Harrison knows a thing or two about jump-starting a biotech company without breaking the bank...."

	Aileron Advances First Stapled Peptide Drug Candidate that Targets Newly-Discovered BAX Activation Mechanism October 22, 2008 "Aileron Therapeutics announced today that one of its proprietary Stapled Peptide compounds, referred to as “BIM-SAHB” in an article published today in Nature..."